Literature DB >> 33752749

Cell specific quantitative iron mapping on brain slices by immuno-µPIXE in healthy elderly and Parkinson's disease.

T Arendt1, M Morawski2,3, I Friedrich1, K Reimann1, S Jankuhn4, E Kirilina5,6, J Stieler1, M Sonntag1, J Meijer4, N Weiskopf5,4, T Reinert5,4.   

Abstract

Iron is essential for neurons and glial cells, playing key roles in neurotransmitter synthesis, energy production and myelination. In contrast, high concentrations of free iron can be detrimental and contribute to neurodegeneration, through promotion of oxidative stress. Particularly in Parkinson's disease (PD) changes in iron concentrations in the substantia nigra (SN) was suggested to play a key role in degeneration of dopaminergic neurons in nigrosome 1. However, the cellular iron pathways and the mechanisms of the pathogenic role of iron in PD are not well understood, mainly due to the lack of quantitative analytical techniques for iron quantification with subcellular resolution. Here, we quantified cellular iron concentrations and subcellular iron distributions in dopaminergic neurons and different types of glial cells in the SN both in brains of PD patients and in non-neurodegenerative control brains (Co). To this end, we combined spatially resolved quantitative element mapping using micro particle induced X-ray emission (µPIXE) with nickel-enhanced immunocytochemical detection of cell type-specific antigens allowing to allocate element-related signals to specific cell types. Distinct patterns of iron accumulation were observed across different cell populations. In the control (Co) SNc, oligodendroglial and astroglial cells hold the highest cellular iron concentration whereas in PD, the iron concentration was increased in most cell types in the substantia nigra except for astroglial cells and ferritin-positive oligodendroglial cells. While iron levels in astroglial cells remain unchanged, ferritin in oligodendroglial cells seems to be depleted by almost half in PD. The highest cellular iron levels in neurons were located in the cytoplasm, which might increase the source of non-chelated Fe3+, implicating a critical increase in the labile iron pool. Indeed, neuromelanin is characterised by a significantly higher loading of iron including most probable the occupancy of low-affinity iron binding sites. Quantitative trace element analysis is essential to characterise iron in oxidative processes in PD. The quantification of iron provides deeper insights into changes of cellular iron levels in PD and may contribute to the research in iron-chelating disease-modifying drugs.

Entities:  

Year:  2021        PMID: 33752749     DOI: 10.1186/s40478-021-01145-2

Source DB:  PubMed          Journal:  Acta Neuropathol Commun        ISSN: 2051-5960            Impact factor:   7.801


  78 in total

Review 1.  Structural and functional aspects of the blood-brain barrier.

Authors:  David J Begley; Milton W Brightman
Journal:  Prog Drug Res       Date:  2003

2.  Accumulation of non-transferrin-bound iron by neurons, astrocytes, and microglia.

Authors:  Glenda M Bishop; Theresa N Dang; Ralf Dringen; Stephen R Robinson
Journal:  Neurotox Res       Date:  2010-04-30       Impact factor: 3.911

3.  Nuclear configuration and neuronal types of the nucleus niger in the brain of the human adult.

Authors:  H Braak; E Braak
Journal:  Hum Neurobiol       Date:  1986

4.  Iron Deficiency Impairs Developing Hippocampal Neuron Gene Expression, Energy Metabolism, and Dendrite Complexity.

Authors:  Thomas W Bastian; William C von Hohenberg; Daniel J Mickelson; Lorene M Lanier; Michael K Georgieff
Journal:  Dev Neurosci       Date:  2016-09-27       Impact factor: 2.984

5.  Association study between iron-related genes polymorphisms and Parkinson's disease.

Authors:  Claire Borie; Francesca Gasparini; Patrice Verpillat; Anne-Marie Bonnet; Yves Agid; Gilles Hetet; Alexis Brice; Alexandra Dürr; Bernard Grandchamp
Journal:  J Neurol       Date:  2002-07       Impact factor: 4.849

6.  Elemental mapping of Neuromelanin organelles of human Substantia Nigra: correlative ultrastructural and chemical analysis by analytical transmission electron microscopy and nano-secondary ion mass spectrometry.

Authors:  Antje Biesemeier; Oliver Eibl; Santhana Eswara; Jean-Nicolas Audinot; Tom Wirtz; Gianni Pezzoli; Fabio A Zucca; Luigi Zecca; Ulrich Schraermeyer
Journal:  J Neurochem       Date:  2016-06-02       Impact factor: 5.372

Review 7.  Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics.

Authors:  Abdel A Belaidi; Ashley I Bush
Journal:  J Neurochem       Date:  2016-02-10       Impact factor: 5.372

8.  Parkinson's disease iron deposition caused by nitric oxide-induced loss of β-amyloid precursor protein.

Authors:  Scott Ayton; Peng Lei; Dominic J Hare; James A Duce; Jessica L George; Paul A Adlard; Catriona McLean; Jack T Rogers; Robert A Cherny; David I Finkelstein; Ashley I Bush
Journal:  J Neurosci       Date:  2015-02-25       Impact factor: 6.167

9.  Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7 T MRI.

Authors:  Anna I Blazejewska; Stefan T Schwarz; Alain Pitiot; Mary C Stephenson; James Lowe; Nin Bajaj; Richard W Bowtell; Dorothee P Auer; Penny A Gowland
Journal:  Neurology       Date:  2013-07-10       Impact factor: 9.910

Review 10.  Adaptive regulation of the brain's antioxidant defences by neurons and astrocytes.

Authors:  Paul S Baxter; Giles E Hardingham
Journal:  Free Radic Biol Med       Date:  2016-06-27       Impact factor: 7.376

View more
  7 in total

Review 1.  Cerebral Iron Deposition in Neurodegeneration.

Authors:  Petr Dusek; Tim Hofer; Jan Alexander; Per M Roos; Jan O Aaseth
Journal:  Biomolecules       Date:  2022-05-17

2.  High Iron and Iron Household Protein Contents in Perineuronal Net-Ensheathed Neurons Ensure Energy Metabolism with Safe Iron Handling.

Authors:  Anja Reinert; Tilo Reinert; Thomas Arendt; Markus Morawski
Journal:  Int J Mol Sci       Date:  2022-01-31       Impact factor: 5.923

Review 3.  Aberrant Cerebral Iron Trafficking Co-morbid With Chronic Inflammation: Molecular Mechanisms and Pharmacologic Intervention.

Authors:  Shaina L Rosenblum; Daniel J Kosman
Journal:  Front Neurol       Date:  2022-03-15       Impact factor: 4.003

Review 4.  Iron, Neuroinflammation and Neurodegeneration.

Authors:  Roberta J Ward; David T Dexter; Robert R Crichton
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

5.  Adaptive cellular response of the substantia nigra dopaminergic neurons upon age-dependent iron accumulation.

Authors:  Kujin Kwon; Hwapyeong Cho; Soyeon Lee; Eun Jeong Cho; Weonjin Yu; Catherine Yen Li Kok; Hyunsoo Shawn Je; Jae-Ick Kim; Hyung Joon Cho; Taejoon Kwon
Journal:  Aging Cell       Date:  2022-08-19       Impact factor: 11.005

6.  Application of the Catecholaminergic Neuron Electron Transport (CNET) Physical Substrate for Consciousness and Action Selection to Integrated Information Theory.

Authors:  Chris Rourk
Journal:  Entropy (Basel)       Date:  2022-01-06       Impact factor: 2.524

7.  Adhesion GPCR GPR56 Expression Profiling in Human Tissues.

Authors:  Fyn Kaiser; Markus Morawski; Knut Krohn; Nada Rayes; Cheng-Chih Hsiao; Marianne Quaas; Gabriela Aust
Journal:  Cells       Date:  2021-12-16       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.